ImmunoPrecise Antibodies Announces Grant of Stock Options

IMMUNOPRECISE ANTIBODIES LTD. („IPA” or the „Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic …

IMMUNOPRECISE ANTIBODIES LTD. ("IPA” or the "Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic ...